NMX-2

N/A

Report date: 2022/07/05 15:20:11

NME

Base Information

Drug NameNMX-2

Drug Alias NameNMX-2

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionInterleukin 11 receptor alpha antagonistsAMP-activated protein kinases activatorsMitogen-activated protein kinase; ERK1/ERK2 inhibitors

TargetsInterleukin 11 receptor alphaAMP-activated protein kinasesMitogen-activated protein kinase; ERK1/ERK2

Therapy Area/IndicationsFibrosisHeart FailureIdiopathic Pulmonary Fibrosis +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNovomedix LLC

China Registration ClassN/A

Develop Information

Active CompaniesNovomedix LLC

Inactive CompaniesN/A

Active IndicationsFibrosisHeart FailureIdiopathic Pulmonary Fibrosis +[5]

Inactive IndicationsN/A

Other Information

ATC CodeN/A